The pharmacological blockade of HCN and SK channels to mimic the DA depleted and chronic L-DOPA treated states recapitulated the changes in rate and pattern of ChI firing, providing new insights into molecular adaptations that follow striatal DA depletion in PD patients receiving L-DOPA therapy. Here, MALAT1 is linked to Parkinson disease.